PMC:7556165 / 27162-27321 JSONTXT

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"708","span":{"begin":6,"end":10},"obj":"Gene"},{"id":"718","span":{"begin":92,"end":96},"obj":"Gene"},{"id":"719","span":{"begin":118,"end":122},"obj":"Gene"}],"attributes":[{"id":"A708","pred":"pubann:denotes","subj":"708","obj":"Gene:116511"},{"id":"A718","pred":"pubann:denotes","subj":"718","obj":"Gene:59272"},{"id":"A719","pred":"pubann:denotes","subj":"719","obj":"Gene:59272"}],"text":" of a MasR antagonist caused inhibition of Ang1–7 effects (Alenina et al., 2008).\nFIGURE 3 ACE2 signalling pathways: ACE2 displays its carboxypeptidase activi"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T2120","span":{"begin":92,"end":96},"obj":"Protein"},{"id":"T2121","span":{"begin":118,"end":122},"obj":"Protein"},{"id":"T2122","span":{"begin":136,"end":152},"obj":"Protein"}],"attributes":[{"id":"A2120","pred":"uniprot_id","subj":"T2120","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A2121","pred":"uniprot_id","subj":"T2121","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A2122","pred":"uniprot_id","subj":"T2122","obj":"https://www.uniprot.org/uniprot/P86516"}],"text":" of a MasR antagonist caused inhibition of Ang1–7 effects (Alenina et al., 2008).\nFIGURE 3 ACE2 signalling pathways: ACE2 displays its carboxypeptidase activi"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T69","span":{"begin":97,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T70","span":{"begin":97,"end":107},"obj":"http://purl.obolibrary.org/obo/GO_0023052"}],"text":" of a MasR antagonist caused inhibition of Ang1–7 effects (Alenina et al., 2008).\nFIGURE 3 ACE2 signalling pathways: ACE2 displays its carboxypeptidase activi"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T71","span":{"begin":97,"end":116},"obj":"http://purl.obolibrary.org/obo/GO_0007165"},{"id":"T72","span":{"begin":97,"end":107},"obj":"http://purl.obolibrary.org/obo/GO_0023052"}],"text":" of a MasR antagonist caused inhibition of Ang1–7 effects (Alenina et al., 2008).\nFIGURE 3 ACE2 signalling pathways: ACE2 displays its carboxypeptidase activi"}

{"project":"LitCovid-PubTator","denotations":[{"id":"708","span":{"begin":6,"end":10},"obj":"Gene"},{"id":"718","span":{"begin":92,"end":96},"obj":"Gene"},{"id":"719","span":{"begin":118,"end":122},"obj":"Gene"}],"attributes":[{"id":"A708","pred":"tao:has_database_id","subj":"708","obj":"Gene:116511"},{"id":"A718","pred":"tao:has_database_id","subj":"718","obj":"Gene:59272"},{"id":"A719","pred":"tao:has_database_id","subj":"719","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" of a MasR antagonist caused inhibition of Ang1–7 effects (Alenina et al., 2008).\nFIGURE 3 ACE2 signalling pathways: ACE2 displays its carboxypeptidase activi"}